Emerging Infectious Diseases (Jun 2019)

Assessment of Economic Burden of Concurrent Measles and Rubella Outbreaks, Romania, 2011–2012

  • Joseph Njau,
  • Denisa Janta,
  • Aurora Stanescu,
  • Sarah S. Pallas,
  • Adriana Pistol,
  • Nino Khetsuriani,
  • Susan Reef,
  • Daniel Ciurea,
  • Cassandra Butu,
  • Aaron S. Wallace,
  • Laura Zimmerman

DOI
https://doi.org/10.3201/eid2506.180339
Journal volume & issue
Vol. 25, no. 6
pp. 1101 – 1109

Abstract

Read online

We estimated the economic impact of concurrent measles and rubella outbreaks in Romania during 2011–2012. We collected costs from surveys of 428 case-patients and caretakers, government records, and health staff interviews. We then estimated financial and opportunity costs. During the study period, 12,427 measles cases and 24,627 rubella cases were recorded; 27 infants had congenital rubella syndrome (CRS). The cost of the outbreaks was US $9.9 million. Cost per case was US $439 for measles, US $132 for rubella, and US $44,051 for CRS. Up to 36% of households needed to borrow money to pay for illness treatment. Approximately 17% of patients continued to work while ill to pay their treatment expenses. Our key study findings were that households incurred a high economic burden compared with their incomes, the health sector bore most costs, and CRS costs were substantial and relevant to include in rubella outbreak cost studies.

Keywords